Brief: Scandinavian Chemotech Q1 Order Intake $230,000
April 1 (Reuters) - Scandinavian ChemoTech AB CMOTECb.ST: STARTS 2025 STRONG WITH Q1 ORDER INTAKE EXCEEDING USD 230,000 Source text: ID:nWkr4xNPK6 Further company coverage: [CMOTECb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Neem's Hill AB
See all newsBrief: Neem's Hill Q2 Loss After Financial Items SEK 2.6 Mln
Brief: Scandinavian ChemoTech Changes Name To Neem's Hill
Brief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue